Why is Gayatri BioOrga. falling/rising?
2025-12-03 00:28:09Robust Price Performance Against Benchmarks Gayatri BioOrganics has demonstrated exceptional returns over multiple time horizons, far exceeding the performance of the Sensex. Over the past week, the stock surged by 7.17%, compared to a modest 0.65% gain in the Sensex. This trend extends over longer periods, with the stock delivering an impressive 94.19% return over the last year, dwarfing the Sensex’s 6.09% rise. Year-to-date, the stock has appreciated by 83.53%, while the benchmark index has gained just 8.96%. Even over five years, Gayatri BioOrganics has outpaced the Sensex with a 146.60% increase versus 90.82% for the index, underscoring sustained investor confidence in the company’s prospects. Technical Strength and Investor Interest On the ...
Read More
Gayatri BioOrganics Hits Upper Circuit Amidst Unprecedented Buying Interest
2025-11-19 10:10:26Gayatri BioOrganics Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon underscores intense demand and the absence of sellers, signalling a potential multi-day circuit scenario for the commodity chemicals company.
Read MoreHow has been the historical performance of Gayatri BioOrga.?
2025-11-14 23:32:59Answer: The historical performance of Gayatri BioOrga shows a challenging trend with minimal revenue generation and consistent losses over the years. Breakdown: Gayatri BioOrga reported net sales of 1.67 Cr in March 2023, but this figure dropped to 0.00 Cr in both March 2024 and March 2025, indicating a complete halt in revenue generation. The total operating income mirrored this trend, remaining at 0.00 Cr for the last two years after a peak in March 2023. The company's expenditures, excluding depreciation, were 2.44 Cr in March 2023, decreasing to 0.45 Cr by March 2025, yet the operating profit continued to be negative, with losses of -0.45 Cr in March 2025 compared to -0.77 Cr in March 2023. The profit before tax also remained negative, with a loss of -0.73 Cr in March 2025. The company's reserves have been in a negative state, reaching -114.68 Cr in March 2025, while shareholder's funds also reflected ...
Read MoreHow has been the historical performance of Gayatri BioOrga.?
2025-11-13 23:12:48Answer: The historical performance of Gayatri BioOrga shows a challenging trend with limited revenue generation and consistent losses over the years. Breakdown: Gayatri BioOrga's net sales remained stagnant at zero for the years ending March 2024 and March 2025, with a slight revenue of 1.67 crore recorded in March 2023. The total operating income followed a similar pattern, reflecting the same figures. The company incurred raw material costs of 1.59 crore in March 2023, but this was not matched by any sales in subsequent years. Employee costs peaked at 0.29 crore in March 2022 but have since decreased to 0.09 crore by March 2025. The total expenditure excluding depreciation was highest in March 2023 at 2.44 crore, leading to an operating profit (PBDIT) of -0.77 crore for that year, which further deteriorated to -0.45 crore by March 2025. Interest expenses increased from 0.03 crore in March 2023 to 0.28 cr...
Read More
Gayatri BioOrganics Ltd Achieves 80.84% Yearly Gain, Outperforming Sensex Amid Positive Buying Trend
2025-11-10 09:50:22Gayatri BioOrganics Ltd is experiencing strong buying activity, reversing a two-day decline. Despite a slight decrease today, the stock has shown resilience with an 80.84% increase over the past year. It opened with a gap up and remains above several moving averages, reflecting positive market sentiment.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jan-2026 | Source : BSECompliance Certificate under Reg.74(5) of SEBI (DP) Regulations 2018
Closure of Trading Window
26-Dec-2025 | Source : BSEClosure of trading window for Unaudited Financial Results for the quarter ending 31.12.2025
Ouctome Of Board Meeting For Results As On 30.09.2025
13-Nov-2025 | Source : BSEBoard meeting outcome
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available